Isolation and Characterization of Complementary DNA Clones Corresponding to Genes Induced in Mouse Epidermis in Vivo by Tumor Promoters1

Total Page:16

File Type:pdf, Size:1020Kb

Isolation and Characterization of Complementary DNA Clones Corresponding to Genes Induced in Mouse Epidermis in Vivo by Tumor Promoters1 [CANCER RESEARCH 50, 1626-1633. March I. 1990] Isolation and Characterization of Complementary DNA Clones Corresponding to Genes Induced in Mouse Epidermis in Vivo by Tumor Promoters1 Staffan Bohm,2 Anna Berghard, Carl Pereswetoff-Morath, and Rune Toftgard Karolimka Institute, Center for BioTechnology, NOVVM, S-I4I 52 Huddinge, Sweden ABSTRACT via the activation of PKC as well as a defect in the regulation of differentiation and/or proliferation in initiated keratinocytes Complementary DNA clones representing genes in SENCAR mouse are assumed to be key events for tumor development in epider epidermis, the expression of which is induced 4 h after one topical application of the tumor promoter 12-0-tetradecanoylphorbol-13-acetate mis. Extensive in vitro studies in a variety of different cell types (TPA) were isolated. Of 56 isolated complementary DNA clones, 32 have resulted in the identification of several TPA-induced genes were identified to be identical to either metallothioneins (MT-I and Mi and different /raws-acting factors regulating their transcrip- ll) or endogenous retroviral like (VL30) sequences. In situ hybridization tional induction. One example is the induction of human me and analysis of mRNA levels in cell fractions separated by density tallothionein IIA,via enhanced AP-1 and AP-2 activity (12,13). gradient centrifugation revealed that Ml induction was restricted to Recent findings indicate that AP-1 consists of heterodimers of keratinocytes in the basal cell layer. Immunohistochemistry and time- oncoproteins belonging to thefos and /'//// gene families (14). In kinetic studies on mRNA levels in mouse epidermis showed that the order to understand mechanisms behind the ability of TPA to increase in MT and VL30 RNAs coincide in time with a TPA-induced transient block in basal cell proliferation (3-12 h after TPA treatment). induce cell kinetic and biological changes associated with tumor promotion it is important to analyze the effects of TPA on gene MT immunoreactivity and transcript levels had returned to control values at a time point (24 h after treatment) when epidermis is known to expression in mouse skin in vivo. Differences with regard to the hyperproliferate. Treatment with other types of tumor promoters showed cell type, physiological state of the cell (i.e., differentiation that MT-I and M 1-II mRNAs were coordinately induced and indicated state, cycling versus quiescent), and microenvironment (in vitro that in-l,2-dioctanoylglycerol, 12-O-retinoylphorbol-13-acetate, and versus intact tissue) are likely to contribute in determining the mezerein induced MT to a lesser degree than TPA. The calcium iono- gene program affected by TPA. The expressions of a limited phore A23187 induced mRNA levels for MTs as well as VL30. VL30 number of genes including ODC (15), c-fos, c-myc (16), transin and MT mRNA levels were not found to be elevated in epidermal tumors (17), /i-actin (18), transforming growth factor 0(19), osteopon- whereas the mRNA level corresponding to glyceraldehyde-3-phosphate tin (20), and certain keratin subunits (21) are known to be dehydrogenase was elevated in tumors and induced by TPA with time- induced by TPA in mouse epidermis. kinetics that correlate with a TPA-induced hyperproliferation. These complementary DNA clones provide useful tools in the study of the gene- In this report we utilized the technique of differential screen regulating effects of TPA in a target tissue relevant for tumor promotion. ing of cDNA libraries to isolate additional genes that are induced in mouse epidermis at an early time point (4 h) after a single topical application of TPA. We describe the identifica INTRODUCTION tion of two groups of genes among the isolated clones, the metallothioneins (MT-I and MT-II) and endogenous retroviral- TPA' was first identified as a potent tumor promoter in the like sequences belonging to the VL30 gene family. We also mouse skin model of multistage carcinogenesis (1, 2). In this describe their temporal pattern of TPA induction, expression model the progression of a normal cell to a benign tumor in skin tumors, induction in response to other types of tumor (papi! Ionia ) may be viewed as a clonal expansion of an epider promoters, and the localized MT expression in epidermis. mal cell initiated by some genetic change, such as activation of the Harvey ras (c-Ha-ras) protooncogene (3-5). Exactly how repeated treatments with TPA can give the initiated cell a MATERIALS AND METHODS proliferative advantage is not known. Normal keratinocytes proliferate in the basal cell layer of epidermis, migrate to the Animal Treatments and RNA Isolation. Female SENCAR mice, 6 to 9 weeks old, were purchased from HaríanSprague-Dawley, Indianap surface during differentiation, and form terminally differen olis, IN. The backs of the mice were shaved 48 h prior to topical tiated enucleated squamous cells that are eventually shed (6). treatment with 10 nmol of TPA (Pharmacia, Uppsala, Sweden). Other Topical application of TPA on mouse skin elicits a strong chemical agents used where RPA (LC Services, Woburn, MA), mezer pleiotropic response, including a transient inhibition of prolif ein (LC Services), 4-O-methyl-TPA (Pharmacia), calcium ionophore eration, followed by a hyperplastic response and inflammation A23187 (Sigma Chemical Co., St. Louis, MO), and sn-l,2-dioctanoyl- (7-10). In addition, a subpopulation of keratinocytes shows an glycerol (Sigma). All agents (concentrations are given in "Results") increase in the rate of terminal differentiation (11). were applied in 200 n\ of acetone. Control mice were treated with 200 Induction of an altered program of gene expression by TPA n\ of acetone only. Mice were killed by cervical dislocation. Papillomas were induced by initiation with 100 nmol of 7,12-dimethyl- Received 8/4/89; revised 11/8/89; accepted 11/28/89. benz(a)anthracene followed by promotion with TPA (3 nmol twice The costs of publication of this article were defrayed in part by the payment weekly) for 12 weeks. Carcinomas were derived from papillomas, in of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. duced as described above, but subsequently treated with 20 mg urethan 1The present study was supported by the Swedish Work Health Fund (Project ¡.p.once weekly to accelerate malignant conversion (22). Total RNA 88-0162). the Swedish Medical Research Council (Project B90-13X-07482-05), was isolated from epidermis (time points are given in "Results") and and by Centrala Försoksdjursnamden (Project 88-01). S. B. is a recipient of a from pools of papillomas or carcinomas as previously described (15). predoctoral fellowship from the Swedish Cancer Research Society. 2To whom requests for reprints should be addressed. Poly(A)+ RNA was isolated by one binding-elution cycle on oligodeox- 'The abbreviations used are: TPA, 12-O-tetradecanoylphorbol-13-acetate; ythymidylate cellulose type T-2 (Collaborative Research, Inc., Lexing PKC. protein kinase C; MT. metallothionein; AP, activator protein; ODC. ton, MA). ornithine decarboxylase; RPA, 12-O-retinoylphorbol-13-acetate; GAPDH. gly- ccraldehyde-3-phosphate dehydrogenase; LTR, long terminal repeal; cDNA, com cDNA Library Construction. A cDNA library was constructed using plementary DNA; poly(A)* RNA. polyadenylated RNA; SSC, standard saline- XgtlO as the cloning vector essentially as described by Huynh et al. citrate (lx SSC is 0.15 M NaCI-0.015 M sodium citrate. pH 7.0). (23). The library was packaged in vitro using a commercially available 1626 Downloaded from cancerres.aacrjournals.org on October 1, 2021. © 1990 American Association for Cancer Research. TUMOR PROMOTER-INDUCED GENES extract system (Promega Biotec, Madison, WI). The resulting cDNA blotted to Hybond-N filter using a Minifold II apparatus (Schleicher & library contained 1 x IO6 independent clones that were stored and Schuell). Chromosomal DNA was isolated from mouse liver (24), screened without amplification. digested with EcoRl or AarnHI (Promega), electrophoresed through a Differential Probe. Poly(A)* RNA prepared from TPA-treated mouse 1% agarose gel, and blotted onto nylon membranes by alkaline transfer epidermis was used as template for synthesis of'2P-labeled cDNA. The (30). Southern and dot blots were hybridized and washed using the conditions used were the same as for the library' construction except same conditions as for Northern analysis. that the reaction mixture contained 10 MM[a-32P]dCTP, [a-32P]dGTP, DNA Sequencing and Analysis. cDNA inserts were separated from and [a-"P]dATP (Amersham Solna. Sweden; specific activity, 800 Ci/ XDNA by electrophoresis through 1% low melting agarose and sub- mmol). "P-labeled cDNA was freed from its template RNA by incu cloned into the £coRIsite of pGEM3Z (Promega) using methods bation in 0.3 M NaOH-10 mM EDTA (2 h, 37°C),neutralized (0.5 described by Struhl (31) and Escherichia coli JM109 as the host. volume 1 M acetic acid), and passed over a Sephadex G-50 M column Double-stranded DNA was used for dideoxy sequencing (T7 Sequenase; (Pharmacia). Single-stranded cDNA (500 ng) was hybridized to USB, Cleveland, OH) with [«-/Aio-15S]dATP(1000 Ci/mmol; NEN/ poly(A)* RNA (25 Mg)prepared from acetone-treated epidermis in 8 ¿il DuPont). Analysis of the DNA sequences was performed using the of 0.5 M sodium phosphate buffer (pH 7.5)-l mM EDTA-0.1% sodium Genetics Computer Group sequence analysis software package, version dodecyl sulfate, overlaid with paraffin oil, and incubated for 20 h at 5.3 (32). 68°C(R0t4500). After dilution in preheated (60°C)0.12 M phosphate In Situ Hybridization. Formalin-fixed skin tissue was embedded in buffer (pH 7.4), separation of single- and double-stranded nucleic acids paraffin, transversally sectioned at 6-7 Mm,and mounted onto micro was performed on a 1-ml (bed volume) hydroxylapatite (DNA grade.
Recommended publications
  • Eukaryotic Non-Coding Rnas: New Targets for Diagnostics and Therapeutics?
    REVIEW Institute of Biochemistry, Department of Chemistry and Biology, Justus Liebig University of Giessen, Germany Eukaryotic non-coding RNAs: new targets for diagnostics and therapeutics? O. Rossbach, A. Bindereif Received June 30, 2015, accepted August 19, 2015 Prof. Dr. Albrecht Bindereif, Institute of Biochemistry, Department of Chemistry and Biology, Justus Liebig University of Giessen, Heinrich-Buff-Ring 58, 35392 Giessen, Germany [email protected] Pharmazie 71: 3–7 (2016) doi: 10.1691/ph.2016.5736 Non-coding RNAs (ncRNAs) in eukaryotes have recently developed to a very active research area in RNA biology, opening up new strategies for diagnosis and therapies of human disease. Here we introduce and describe the most important classes of eukaryotic ncRNAs: microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs). We further discuss new RNA-based diagnostic and therapeutic concepts. 1. Introduction: Coding and non-coding RNAs in eukaryotes The deciphering of the human genome sequence in 2000 marked a unique breakthrough in modern molecular biology. An impor- tant insight was the unexpectedly low number of protein-coding genes (about 20,000), which lagged far behind previous esti- mates. This number revealed that only approximately two percent of the human genome is transcribed into messenger RNA (mRNA). However, the human genome sequence itself did not provide an explanation for the enormous complexity of the human organ- ism compared with, for example, the more primitive worm Caenorhabditis elegans (C. elegans) that carries a similar num- Fig. 1: Non-coding RNAs as an emerging field. The rapid development of the ber of protein-coding genes.
    [Show full text]
  • A Pirna-Like Small RNA Interacts with and Modulates P-ERM Proteins in Human Somatic Cells
    ARTICLE Received 18 Mar 2015 | Accepted 27 Apr 2015 | Published 22 June 2015 DOI: 10.1038/ncomms8316 OPEN A piRNA-like small RNA interacts with and modulates p-ERM proteins in human somatic cells Yuping Mei1, Yuyan Wang1,2, Priti Kumari3, Amol Carl Shetty3, David Clark1, Tyler Gable1, Alexander D. MacKerell4,5, Mark Z. Ma1, David J. Weber5,6, Austin J. Yang5, Martin J. Edelman5 & Li Mao1,5 PIWI-interacting RNAs (piRNAs) are thought to silence transposon and gene expression during development. However, the roles of piRNAs in somatic tissues are largely unknown. Here we report the identification of 555 piRNAs in human lung bronchial epithelial (HBE) and non-small cell lung cancer (NSCLC) cell lines, including 295 that do not exist in databases termed as piRNA-like sncRNAs or piRNA-Ls. Distinctive piRNA/piRNA-L expression patterns are observed between HBE and NSCLC cells. piRNA-like-163 (piR-L-163), the top down- regulated piRNA-L in NSCLC cells, binds directly to phosphorylated ERM proteins (p-ERM), which is dependent on the central part of UUNNUUUNNUU motif in piR-L-163 and the RRRKPDT element in ERM. The piR-L-163/p-ERM interaction is critical for p-ERM’s binding capability to filamentous actin (F-actin) and ERM-binding phosphoprotein 50 (EBP50). Thus, piRNA/piRNA-L may play a regulatory role through direct interaction with proteins in physiological and pathophysiological conditions. 1 Department of Oncology and Diagnostic Sciences, University of Maryland School of Dentistry, 650W Baltimore Street, Baltimore, Maryland 21201, USA. 2 Department of Thoracic Medical Oncology, Peking University Cancer Hospital and Institute, Beijing 100142, China.
    [Show full text]
  • Hammerhead Ribozymes Against Virus and Viroid Rnas
    Hammerhead Ribozymes Against Virus and Viroid RNAs Alberto Carbonell, Ricardo Flores, and Selma Gago Contents 1 A Historical Overview: Hammerhead Ribozymes in Their Natural Context ................................................................... 412 2 Manipulating Cis-Acting Hammerheads to Act in Trans ................................. 414 3 A Critical Issue: Colocalization of Ribozyme and Substrate . .. .. ... .. .. .. .. .. ... .. .. .. .. 416 4 An Unanticipated Participant: Interactions Between Peripheral Loops of Natural Hammerheads Greatly Increase Their Self-Cleavage Activity ........................... 417 5 A New Generation of Trans-Acting Hammerheads Operating In Vitro and In Vivo at Physiological Concentrations of Magnesium . ...... 419 6 Trans-Cleavage In Vitro of Short RNA Substrates by Discontinuous and Extended Hammerheads ........................................... 420 7 Trans-Cleavage In Vitro of a Highly Structured RNA by Discontinuous and Extended Hammerheads ........................................... 421 8 Trans-Cleavage In Vivo of a Viroid RNA by an Extended PLMVd-Derived Hammerhead ........................................... 422 9 Concluding Remarks and Outlooks ........................................................ 424 References ....................................................................................... 425 Abstract The hammerhead ribozyme, a small catalytic motif that promotes self- cleavage of the RNAs in which it is found naturally embedded, can be manipulated to recognize and cleave specifically
    [Show full text]
  • Questions with Answers- Nucleotides & Nucleic Acids A. the Components
    Questions with Answers- Nucleotides & Nucleic Acids A. The components and structures of common nucleotides are compared. (Questions 1-5) 1._____ Which structural feature is shared by both uracil and thymine? a) Both contain two keto groups. b) Both contain one methyl group. c) Both contain a five-membered ring. d) Both contain three nitrogen atoms. 2._____ Which component is found in both adenosine and deoxycytidine? a) Both contain a pyranose. b) Both contain a 1,1’-N-glycosidic bond. c) Both contain a pyrimidine. d) Both contain a 3’-OH group. 3._____ Which property is shared by both GDP and AMP? a) Both contain the same charge at neutral pH. b) Both contain the same number of phosphate groups. c) Both contain the same purine. d) Both contain the same furanose. 4._____ Which characteristic is shared by purines and pyrimidines? a) Both contain two heterocyclic rings with aromatic character. b) Both can form multiple non-covalent hydrogen bonds. c) Both exist in planar configurations with a hemiacetal linkage. d) Both exist as neutral zwitterions under cellular conditions. 5._____ Which property is found in nucleosides and nucleotides? a) Both contain a nitrogenous base, a pentose, and at least one phosphate group. b) Both contain a covalent phosphodister bond that is broken in strong acid. c) Both contain an anomeric carbon atom that is part of a β-N-glycosidic bond. d) Both contain an aldose with hydroxyl groups that can tautomerize. ___________________________________________________________________________ B. The structures of nucleotides and their components are studied. (Questions 6-10) 6._____ Which characteristic is shared by both adenine and cytosine? a) Both contain one methyl group.
    [Show full text]
  • Mirna Detection Using a Rolling Circle Amplification and RNA
    biosensors Article MiRNA Detection Using a Rolling Circle Amplification and RNA-Cutting Allosteric Deoxyribozyme Dual Signal Amplification Strategy Chenxin Fang, Ping Ouyang, Yuxing Yang, Yang Qing, Jialun Han, Wenyan Shang, Yubing Chen and Jie Du * State Key Laboratory of Marine Resource Utilization in South China Sea, College of Materials Science and Engineering, Hainan University, Haikou 570228, China; [email protected] (C.F.); [email protected] (P.O.); [email protected] (Y.Y.); [email protected] (Y.Q.); [email protected] (J.H.); [email protected] (W.S.); [email protected] (Y.C.) * Correspondence: [email protected] Abstract: A microRNA (miRNA) detection platform composed of a rolling circle amplification (RCA) system and an allosteric deoxyribozyme system is proposed, which can detect miRNA-21 rapidly and efficiently. Padlock probe hybridization with the target miRNA is achieved through complementary base pairing and the padlock probe forms a closed circular template under the action of ligase; this circular template results in RCA. In the presence of DNA polymerase, RCA proceeds and a long chain with numerous repeating units is formed. In the presence of single-stranded DNA (H1 and H2), multi-component nucleic acid enzymes (MNAzymes) are formed that have the ability to cleave substrates. Finally, substrates containing fluorescent and quenching groups and magnesium ions are added to the system to activate the MNAzyme and the substrate cleavage reaction, thus achieving fluorescence intensity amplification. The RCA–MNAzyme system has dual signal amplification and presents a sensing platform that demonstrates broad prospects in the analysis and detection of Citation: Fang, C.; Ouyang, P.; Yang, nucleic acids.
    [Show full text]
  • Neo-Cloo2 B2 O 1 B 1 (3) REVERSE TRANSCRIPTION RNA PROCESSING
    |||||||||||||| O US005436141A United States Patent (19) 11 Patent Number: 5,436,141 Miyata et al. (45) Date of Patent: Jul. 25, 1995 54 METHOD FOR SYNTHESIZING STABLE 56) References Cited SINGLE-STRANDED CONAN EUKARYOTES BY MEANS OF A U.S. PATENT DOCUMENTS BACTERAL RETRON AND PRODUCTS 5,079,151 1/1992 Lampson et al. ................ 435/91.51 75 Inventors: Shohei Miyata, Misato, Japan; FOREIGN PATENT DOCUMENTS Atsushi Ohshima, Highland Park, 0132309 1/1985 European Pat. Off. ... C12N 15/00 N.J.; Sumiko Inouye; Masayori Inouye, both of Bridgewater, N.J. OTHER PUBLICATIONS Y o Dhundale et al., J. Bact, vol. 170, 1988, pp. 5620-5624. 73) Assignee: University of Medicine and Dentistry Lampson et al., Science, vol. 243, 1989, pp. 1033-1038. of New Jersey, Newark, N.J. Sambrook et al., Molecular Cloning: A Laboratory Man ual, Cold Spring Harbor Laboratory Press, 1989, pp. 21 Appl. No.: 753,110 16.15-16.16. 22 Filed: Aug. 30, 1991 Primary Examiner-Richard A. Schwartz Assistant Examiner-James Ketter Related U.S. Application Data Attorney, Agent, or Firm-Weiser & Associates (63) Continuation-in-part of Ser. No. 315,427, Feb. 24, 1989, 57 ABSTRACT Pat. No. 5,979,151, and a continuation in part of Ser. A method for producing in vivo stable single-stranded No. 315,316, Feb. 24, 1989, Pat. No. 5,320,958, and a DNAs in eucaryotic cells. The DNAs are multicopy Eup ii.g 1. single-stranded DNA (msDNA) structures constituted 517,946, May 2, 1990, and a continuation-in-part of Ser. by a RNA and a DNA portion.
    [Show full text]
  • De Novo Nucleic Acids: a Review of Synthetic Alternatives to DNA and RNA That Could Act As † Bio-Information Storage Molecules
    life Review De Novo Nucleic Acids: A Review of Synthetic Alternatives to DNA and RNA That Could Act as y Bio-Information Storage Molecules Kevin G Devine 1 and Sohan Jheeta 2,* 1 School of Human Sciences, London Metropolitan University, 166-220 Holloway Rd, London N7 8BD, UK; [email protected] 2 Network of Researchers on the Chemical Evolution of Life (NoR CEL), Leeds LS7 3RB, UK * Correspondence: [email protected] This paper is dedicated to Professor Colin B Reese, Daniell Professor of Chemistry, Kings College London, y on the occasion of his 90th Birthday. Received: 17 November 2020; Accepted: 9 December 2020; Published: 11 December 2020 Abstract: Modern terran life uses several essential biopolymers like nucleic acids, proteins and polysaccharides. The nucleic acids, DNA and RNA are arguably life’s most important, acting as the stores and translators of genetic information contained in their base sequences, which ultimately manifest themselves in the amino acid sequences of proteins. But just what is it about their structures; an aromatic heterocyclic base appended to a (five-atom ring) sugar-phosphate backbone that enables them to carry out these functions with such high fidelity? In the past three decades, leading chemists have created in their laboratories synthetic analogues of nucleic acids which differ from their natural counterparts in three key areas as follows: (a) replacement of the phosphate moiety with an uncharged analogue, (b) replacement of the pentose sugars ribose and deoxyribose with alternative acyclic, pentose and hexose derivatives and, finally, (c) replacement of the two heterocyclic base pairs adenine/thymine and guanine/cytosine with non-standard analogues that obey the Watson–Crick pairing rules.
    [Show full text]
  • Design and Switch of Catalytic Activity with the Dnazyme–Rnazyme Combination
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 581 (2007) 1763–1768 Design and switch of catalytic activity with the DNAzyme–RNAzyme combination Yongjie Sheng, Zhen Zeng, Wei Peng, Dazhi Jiang, Shuang Li, Yanhong Sun, Jin Zhang* Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, Jilin University, Changchun 130023, PR China Received 12 January 2007; revised 9 March 2007; accepted 16 March 2007 Available online 2 April 2007 Edited by Judit Ova´di backbone DNA with a regulating sequence [12]. Compared to Abstract Design and switch of catalytic activity in enzymology remains a subject of intense investigation. Here, we employ a the linear hammerhead ribozyme, the stability of the circular DNAzyme–RNAzyme combination strategy for construction of RNA–DNA enzyme was substantially enhanced. Furthering a 10–23 deoxyribozyme-hammerhead ribozyme combination that this approach, we substituted the hammerhead ribozyme with targets different sites of the b-lactamase mRNA. The 10–23 the more efficient and more stable 10–23 deoxyribozyme, while deoxyribozyme-hammerhead ribozyme combination gene was the backbone DNA was replaced by the single-stranded repli- cloned into phagemid vector pBlue-scriptIIKS (+). In vitro the cation-competent vector M13mp18 (7.25 kb), thus successfully single-strand recombinant phagemid vector containing the com- constructing a novel replicating circular deoxyribozyme, which bination sequence exhibited 10–23 deoxyribozyme activity, and displayed 10–23 deoxyribozyme activities both in vitro and in the linear transcript displayed hammerhead ribozyme activity. bacteria [13,14]. In bacteria, the 10–23 deoxyribozyme-hammerhead ribozyme Here, we report the combination of 10–23 deoxyribozyme combination inhibited the b-lactamase expression and repressed the growth of drug-resistant bacteria.
    [Show full text]
  • LESSON 4 Using Bioinformatics to Analyze Protein Sequences
    LESSON 4 Using Bioinformatics to 4 Analyze Protein Sequences Introduction In this lesson, students perform a paper exercise designed to reinforce the student understanding of the complementary nature of DNA and how that complementarity leads to six potential protein reading frames in any given DNA sequence. They also gain familiarity with the circular format codon table. Students then use the bioinformatics tool ORF Finder to identify the reading frames in their DNA sequence from Lesson Two and Lesson Three, and to select Class Time the proper open reading frame to use in a multiple sequence alignment with 2 class periods (approximately 50 their protein sequences. In Lesson Four, students also learn how biological minutes each). anthropologists might use bioinformatics tools in their career. Prior Knowledge Needed • DNA contains the genetic information Learning Objectives that encodes traits. • DNA is double stranded and At the end of this lesson, students will know that: anti-parallel. • Each DNA molecule is composed of two complementary strands, which are • The beginning of a DNA strand is arranged anti-parallel to one another. called the 5’ (“five prime”) region and • There are three potential reading frames on each strand of DNA, and a total the end of a DNA strand is called the of six potential reading frames for protein translation in any given region of 3’ (“three prime”) region. the DNA molecule (three on each strand). • Proteins are produced through the processes of transcription and At the end of this lesson, students will be able to: translation. • Amino acids are encoded by • Identify the best open reading frame among the six possible reading frames nucleotide triplets called codons.
    [Show full text]
  • Conditional Deoxyribozyme−Nanoparticle Conjugates For
    www.acsami.org Research Article Conditional Deoxyribozyme−Nanoparticle Conjugates for miRNA- Triggered Gene Regulation Jiahui Zhang, Rong Ma, Aaron Blanchard, Jessica Petree, Hanjoong Jo,* and Khalid Salaita* Cite This: ACS Appl. Mater. Interfaces 2020, 12, 37851−37861 Read Online ACCESS Metrics & More Article Recommendations *sı Supporting Information ABSTRACT: DNA−nanoparticle (NP) conjugates have been used to knockdown gene expression transiently and effectively, making them desirable tools for gene regulation therapy. Because DNA−NPs are constitutively active and are rapidly taken up by most cell types, they offer limited control in terms of tissue or cell type specificity. To take a step toward solving this issue, we incorporate toehold-mediated strand exchange, a versatile molec- ular programming modality, to switch the DNA−NPs from an inactive state to an active state in the presence of a specific RNA input. Because many transcripts are unique to cell subtype or disease state, this approach could one day lead to responsive nucleic acid therapeutics with enhanced specificity. As a proof of concept, we designed conditional deoxyribozyme−nanoparticles (conditional DzNPs) that knockdown tumor necrosis factor α (TNFα) mRNA upon miR-33 triggering. We demonstrate toehold- mediated strand exchange and restoration of TNFα DNAzyme activity in the presence of miR-33 trigger, with optimization of the preparation, configuration, and toehold length of conditional DzNPs. Our results indicate specific and strong ON/OFF response of conditional DzNPs to the miR-33 trigger in buffer. Furthermore, we demonstrate endogenous miR-33-triggered knockdown of TNFα mRNA in mouse macrophages, implying the potential of conditional gene regulation applications using these DzNPs.
    [Show full text]
  • Cytoplasmic Synthesis of Endogenous Alu Complementary DNA Via Reverse Transcription and Implications in Age-Related Macular Degeneration
    Cytoplasmic synthesis of endogenous Alu complementary DNA via reverse transcription and implications in age-related macular degeneration Shinichi Fukudaa,b,c,1, Akhil Varshneya,b,1, Benjamin J. Fowlerd, Shao-bin Wanga,b, Siddharth Narendrana,b,e, Kameshwari Ambatia,b, Tetsuhiro Yasumad,f, Joseph Magagnolig,h, Hannah Leunga,b, Shuichiro Hiraharaa,b,i, Yosuke Nagasakaa,b, Reo Yasumaa,b,f, Ivana Apicellaa,b, Felipe Pereiraa,b,j, Ryan D. Makina,b, Eamonn Magnerk, Xinan Liuk, Jian Suna,b, Mo Wangl, Kirstie Bakerl, Kenneth M. Marionl, Xiwen Huangk, Elmira Baghdasaryanl,m, Meenakshi Ambatia,b,n, Vidya L. Ambatin, Akshat Pandeya,b, Lekha Pandyaa,b, Tammy Cummingsg,h, Daipayan Banerjeea,b, Peirong Huanga,b, Praveen Yerramothua,b, Genrich V. Tolstonogo, Ulrike Heldp, Jennifer A. Erwinq, Apua C. M. Paquolaq, Joseph R. Herdyr, Yuichiro Ogurai, Hiroko Terasakif, Tetsuro Oshikac, Shaban Darwishs,t, Ramendra K. Singhs, Saghar Mozaffaris, Deepak Bhattaraiu, Kyung Bo Kimu, James W. Harding,v, Charles L. Bennettg,h,w, David R. Hintonx,y, Timothy E. Hansonz,aa, Christian Röverbb, Keykavous Parangs, Nagaraj Kerura,b,cc,dd, Jinze Liuk, Brian C. Werneree, S. Scott Suttong,h, Srinivas R. Saddal,m, Gerald G. Schumannp, Bradley D. Gelfanda,b,ff, Fred H. Gager,2, and Jayakrishna Ambatia,b,dd,gg,2 aCenter for Advanced Vision Science, School of Medicine, University of Virginia, Charlottesville, VA 22908; bDepartment of Ophthalmology, School of Medicine, University of Virginia, Charlottesville, VA 22908; cDepartment of Ophthalmology, University of Tsukuba, Ibaraki
    [Show full text]
  • Transitioning to DNA Genomes in an RNA World
    INSIGHT ORIGIN OF LIFE Transitioning to DNA genomes in an RNA world The unexpected ability of an RNA polymerase ribozyme to copy RNA into DNA has ramifications for understanding how DNA genomes evolved. RAZVAN COJOCARU AND PETER J UNRAU In modern metabolism, protein-based Related research article Samanta B, Joyce enzymes called reverse transcriptases can copy GF. 2017. A reverse transcriptase ribozyme. RNA to produce molecules of complementary eLife 6:e31153. DOI: 10.7554/eLife.31153 DNA. Other enzymes can promote the produc- tion of DNA nucleotides (the building blocks of DNA molecules) from RNA nucleotides via chal- lenging chemical reactions. So how did the first DNA genomes come to be? There are two pos- or as long as history has been recorded, sibilities within the framework of the RNA world. humanity has tried to answer the ancient In the first, protein enzymes evolved before question of our origins. The ‘central DNA genomes. In the second, the RNA world F contained RNA polymerase ribozymes that were dogma’ of molecular biology, first stated by Fran- able to produce single-stranded complementary cis Crick in 1958, represented a major step for- DNA and then convert it into stable double- ward in our efforts to answer this question stranded DNA genomes. (Figure 1A; Crick, 1958). In this model, the A number of laboratories around the world genetic information stored in DNA is transcribed are trying to build ribozymes that can sustain to produce RNA, which is then translated by the RNA replication (Wang et al., 2011; ribosome to produce chains of amino acids.
    [Show full text]